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Abstract
Aims: To determine the incidence and clinical features of patients diagnosed with pilomatrixoma.
Patients and Method: A retrospective analysis was made of 205 cases of pilomatrixoma diagnosed according to 
clinical and histological criteria, with an evaluation of the incidence, patient age at presentation, gender, lesion 
location and size, single or multiple presentation, differential diagnosis, histopathological and clinical findings 
and relapses.
Results: Pilomatrixoma was seen to account for 1.04% of all benign skin lesions. It tended to present in pediat-
ric patients – almost 50% corresponding to individuals under 20 years of age – with a slight male predilection 
(107/98). Approximately 75% of all cases presented as single lesions measuring less than 15 mm in diameter. 
Multiple presentations were seen in 2.43% of cases. The most frequent locations were the head and orofacial 
zones (particularly the parotid region), with over 50% of all cases, followed by the upper (23.9%) and lower limbs 
(12.7%). Only one relapse was documented following simple lesion excision.
Conclusions: The frequency of pilomatrixomas was 1.04% of all benign skin lesions – the lesions being predomi-
nantly located in the maxillofacial area. Due to the benign features of this disorder, simple removal of the lesion 
is considered to be the treatment of choice, and is associated with a very low relapse rate.
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Introduction
The term pilomatrixoma was introduced by Forbis and 
Helwing (1) in 1961, in reference to a hair cell-derived 
lesion that up until that time had been known as Mal-
herbe’s calcifying epithelioma (2). Following histo-
chemical and electron microscopic studies, the idea that 
these lesions derived from sebaceous glands was dis-
carded, and the neoplasm was shown to derive from the 
primitive basal cells of the epidermis. The lesions are 
posteriorly found in the dermis or in the subcutaneous 
tissues, and differentiate towards hair matrix cells with 
uncontrolled tumor-type proliferation (3).
Pilomatrixoma is classified as a benign skin appendage 
tumor belonging to the group of suborganoid tumors 
with hair differentiation (4).
Clinically the tumor is hard, well circumscribed, slow-
growing and mobile in the early stages. It is usually 
covered by skin of normal appearance, though in some 
cases there may be skin color changes secondary to epi-
thelial thinning, or even ulceration. The lesion usually 
produces no symptoms, though some patients may ex-
perience pain in response to palpation, or itching.
Pilomatrixoma may be located in any part of the body 
except the palms and soles, and shows a predilection for 
the maxillofacial region.
The aim of the present study was to determine the in-
cidence and the clinical and histological characteristics 
of 205 patients with skin lesions diagnosed as piloma-
trixoma. 
Patients and Methods
A retrospective review was made of 222,319 histologi-
cal samples from Vall d’Hebron General University 
Hospital (Barcelona, Spain), documenting a total of 
179 established cases of pilomatrixoma in the period 
between 1972-1988. In addition, 26 lesions diagnosed 
as corresponding to pilomatrixoma were prospectively 
identified in Granollers General Hospital and the Te-
knon Medical Center (Barcelona, Spain) between the 
years 1989 and 2005.
The following data were collected from the clinical files: 
patient age at presentation, gender, lesion location and 
size, possible etiological parameters, single or multiple 
presentation, differential diagnosis, histopathological 
features and relapses. 
A descriptive statistical study was made using the Sta-
tistical Package for the Social Sciences (SPSS version 
12.0; SPSS, Chicago, USA; license of the University of 
Barcelona).
Results
In order to determine the incidence of this lesion, we lim-
ited the analysis to the cases gathered from the retrospec-
tive review of the 222.319 histological samples from Vall 
d’Hebron General Hospital. Of these samples, 17,091 were 
classified as benign skin tumors. Our series of pilomatrix-
omas accounted for 0.08% of the global surgical pathology 
of this hospital center. Focusing only on benign dermato-
logical lesions, the corresponding incidence was 1.04%.
The mean patient age was 27 years (range 6 months - 79 
years), and in 46.4% of the cases the diagnosis was es-
tablished in the first two decades of life (Fig. 1).
A total of 201 patients (98%) were caucasians, three 
were black and one was asian. A slight male predilec-
tion was observed in our series: 98 females (47.8%) and 
107 males (52.2%).
The lesion diameter at presentation ranged from 1-50 
mm, though a full 154 cases (75.1%) were less than 15 
mm in size (Fig. 2).
Three patients reported previous insect bites in the af-
fected area, while two had shown intradermoreaction 
(vaccine), two cases were preceded by traumatisms, and 
one patient presented a history of alopecia areata.
Of the global 205 cases, 200 represented solitary pres-
entations (97.56%), while 5 (2.43%) consisted of mul-
tiple lesions. Among the latter, four patients presented 
two pilomatrixomas, while only one patient presented 
three lesions.
The location of the lesions is shown in table 1, and their 
clinical appearance can be seen in fig. 3.
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Fig. 1. Patient distribution by age groups and gender. Fig. 2. Lesion size distribution in relation to patient 
gender.
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Simple resection was carried out in all cases fig. 4, fo-
llowed by a single relapse. No malignant transforma-
tions were reported.
The histological study showed a generally circum-
scribed and well delimited subepidermal nodular tumor 
consisting of a proliferation of monomorphic and mon-
olayered basophilic cells, without atypias. These cells 
tended to evolve towards phantom cells, and areas of 
variable keratinization and calcification were observed. 
Multinucleated cells participating in foreign body reac-
tions were identified surrounding the phantom cells and 
keratinized zones (Fig. 5).
Discussion
Pilomatrixoma is a relatively infrequent tumor, with a 
highly variable incidence depending on the literature 
source. In our series, the incidence was 1.04% of all 
benign skin tumors, while other authors (5,6) have re-
ported figures of between 0.001% and 0.0031% of all 
dermatological histology specimens. Such discrepancy 
reflects the variability of the data sources involved in 
the different series published to date (5,6).
While pilomatrixoma can develop at any age, two maxi-
mum frequency peaks have been identified: one in the 
pediatric age range and the other in the sixth decade 
of life (7). Our results are similar to those reported by 
other investigators (5-8). As to the gender distribution 
of these tumors, we recorded a slight male predilection, 
unlike other authors who report a predominance among 
females (5,6,8,9). 
The etiology of pilomatrixoma is subject to controversy. 
In coincidence with Forbis and Helwing (1), we record-
ed antecedents of traumatism, insect bites or surgery – 
though in only a very low proportion of cases (3.9%). 
Unlike other authors (5), we observed no familial presen-
tations – though the retrospective study design involved 
would have made it difficult to detect any such pattern.
The most frequent locations were the head and max-
illofacial zones (particularly the facial region), in co-
incidence with the observations of other case series 
(5,6,8,10). The locations were followed in decreasing or-
Location No. of cases Percentage (%) 
Cervico-
maxillofacial 
region 
Preauricular 36 17.1 
Nasogenian 19 9.0 
Scalp 9 4.3 
Palpebral 5 2.4 
Other facial zones 4 1.9 
Neck 41 19.4 
Limbs
Arms 54 25.6 
Legs 29 13.7 
Other areas 14 6.6 
Table 1. Locations of pilomatrixoma. Note that the total number 
of lesions is 211, since 4 patients presented multiple pilomatrixo-
mas.
A B
Fig. 3. Clinical appearance of two pilomatrixomas: one in the parotid 
region (A) and the other in the lower palpebral zone (B).
Fig. 4. Resection of a pilomatrixoma in the 
parotid region.
Fig. 5. Histological section of the skin, showing a circumscribed 
and well delimited subepidermal nodular lesion (A). Under higher 
magnification (B), intense monomorphic and monolayer basal cell 
proliferation is seen. No cellular atypias are observed. The basal cell 
proliferation involves abrupt keratinization, with the appearance of 
shadow or phantom cells. Surrounding the keratinized zones are epi-
theloid cells and giant multinucleated cells in the context of a foreign 
body reaction.
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der of frequency by the upper limbs, legs and trunk. The 
most commonly affected facial zone is the preauricular 
(parotid) region, followed by the nasogenian zone (11).
While pilomatrixoma generally manifests as a single le-
sion, multiple pilomatrixomas in one same individual 
were observed in 2.43% of our cases – in coincidence 
with the reports found in the literature (1,6,8).
The diagnosis of pilomatrixoma is fundamentally clini-
cal, though complementary studies are needed to es-
tablish a differential diagnosis with other lesions such 
as dermal and subcutaneous masses (sebaceous cysts, 
epidermoid cysts, basal cell epitheliomas and neurofi-
bromas), calcified lesions (calcified epidermoid cyst, 
foreign body reactions or calcified hematomas) and, in 
the specific case of preauricular lesions, primary and 
secondary parotid gland tumor pathology (12,13).
The routinely requested diagnostic test is a plain soft-tis-
sue radiographic study, which sometimes reveals tenuous 
radiopaque and diffusely distributed lesions. Computed 
tomography (CT) offers important advantages particularly 
in those cases where tumor exeresis may place other struc-
tures at risk – as in the preauricular region. In some cases 
selective external carotid angiography may be needed to 
rule out the presence of a vascular tumor in this territory 
(14). Other authors (15,16) recommend ultrasound for diag-
nosing pilomatrixoma in children, since it is noninvasive, 
rapid and inexpensive, and offers reliable imaging that can 
be of help in planning the treatment strategy.
The treatment of pilomatrixoma comprises simple tu-
mor resection (17). Relapses are probably due to incom-
plete removal of the lesion, with a rate of 2-6% (1). This 
range exceeds the relapse rate recorded in our series 
(0.48%). In some cases, due to the volume of the lesion, 
or in the presence of adherences to the epidermis, skin 
grafts may be required to cover the resection defect. 
Other authors have proposed oral retinoid administra-
tion after successfully controlling a case of multiple pi-
lomatrixomas in a dog (18).
The malignization of pilomatrixoma is rare. In the lit-
erature some 60 cases of malignant transformation have 
been documented to date. The principal indicators of 
malignancy are cellular pleomorphism, frequent mitotic 
figures and atypias, central necrosis and infiltration of 
the skin, soft tissues and lymphatic and vascular ele-
ments. The malignant version of pilomatrixoma is more 
frequent in males (with a 3:1 predominance over fe-
males) and in elderly individuals (60% are over 40 years 
of age). The location of malignant pilomatrixoma shows 
the same distribution as the benign version of the tumor. 
Once the diagnosis has been confirmed, management 
consists of radical excision with adequate resection 
margins, due to the high associated relapse rate (49% of 
controlled cases) (15,19,20). In our series no malignant 
variants were diagnosed.
Distant metastases are rare, with only 6 cases described 
to date in the literature. Patient survival in such cases 
has been 3-18 months from the time of diagnosis of 
metastatic disease (15,20).
Conclusions
The frequency of pilomatrixomas in our series was 
1.04% among all benign skin lesions. This entity was 
predominantly located in the maxillofacial area, it 
therefore being essential for dentists to be familiarized 
with these lesions. Due to the benign nature of piloma-
trixomas, simple removal of the lesion is considered to 
be the treatment of choice, with a very low relapse rate.
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